J Bone Oncol, Oct 2026
This preclinical study examined PEMF exposure in osteosarcoma and osteoblast cell lines and in a mouse model. Researchers reported reduced proliferation and migration of osteosarcoma cells, markers of ferroptosis, and support for normal bone-forming cells. The authors describe the work as early-stage and state that long-term safety and effectiveness have not been evaluated.
Read the study: PubMed 42750945 · DOI 10.1016/j.jbo.2026.100801
Research curated via the Association of PEMF Professionals. This summary is for educational purposes only and is not medical advice. MagnaWave devices are not intended to diagnose, treat, cure, or prevent any disease.